None listed
Conditions
Interventions
Drug : To ensure allocation concealment, the sequence will be secured in sequentially numbered, opaque envelopes, open only after participant enrollment. These envelopes will be prepared by a study st
Sponsors
Keimyung University Dongsan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients aged 18 years or older 2) Patients with rectal cancer at clinical stage T3, T4, or with lymph node metastasis 3) Individuals who have undergone chemoradiation followed by anterior resection and ileostomy construction 4) Individuals who voluntarily agree to participate in this trial and have signed a written consent form
Exclusion criteria
Exclusion criteria: 1) Patients previously diagnosed with or suspected of having inflammatory bowel disease 2) Patients for whom surgical treatment is contraindicated due to other medical conditions 3) Patients with difficulties in ileostomy restoration due to complications such as anastomotic leakage or obstruction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low Anterior Resection Syndrome score | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in blood test indicators;Total hospital stay;Complications within 30 days | — |
Countries
Korea, Republic of
Contacts
Public ContactWoon Kyung Jeong
Keimyung University Dongsan Hospital
Outcome results
None listed